MLAB
NASDAQ
US
Mesa Laboratories, Inc. - Common Stock
$91,08
▲ +$2,62
(+2,96%)
Vol. 91K
6
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$433.5M
ROE
-0,9%
Margine
-0,6%
D/E
97,97
Beta
0,88
Rendimento div.
0,82%
52W
$55–$155
Consenso Wall Street
9 analisti · Apr 20263
Acquisto forte
3
Compra
3
Mantieni
0
Vendi
0
Vendita forte
66,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
AZTA
Azenta Inc
$1.5B
BLFS
BioLife Solutions Inc
$1.2B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
CYRX
Cryoport Inc
P/E 7,1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
LAB
Standard BioTools Inc
$492.2M
Utili
Tasso di battuta: 75,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,28 | $0,65 | +$0,37 |
| Set 2025 | $0,16 | $0,45 | +$0,29 |
| Giu 2025 | $0,45 | $0,85 | +$0,40 |
| Mar 2025 | $1,11 | $-1,31 | $-2,42 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -0.4% | -1.3% | -0.4% | -0.4% | -0.9% | -0.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 8.0% | -0.8% | -0.3% | -0.3% | -0.6% | -0.6% |
| Gross Margin | 62.0% | 62.6% | 62.1% | 62.1% | 62.1% | 62.1% |
| D/E Ratio | 105.04 | 111.34 | 105.04 | 105.04 | 97.97 | 97.97 |
| Current Ratio | 0.66 | 0.63 | 0.66 | 0.66 | 2.02 | 2.02 |
Rapporti chiave
ROA (TTM)
-0,4%
P/S (TTM)
1,77
P/B
4,0
EPS (TTM)
$-0,31
CF/Share
$6,17
Crescita ricavi 3A
+9,4%
52W High
$155,12
52W Low
$55,45
$55,45
Intervallo 52 settimane
$155,12
Як MLAB виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній
Оцінка MLAB vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
sotto
peer
(32,5)
vs Peer
vs Settore
Valore equo
P/S
1,8
▼
54%
sotto
peer
(3,8)
vs Peer
vs Settore
Sottovalutato
P/B
4,0
▲
8%
sopra
peer
(3,7)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
0,8%
▲
70%
sopra
peer
(0,5%)
vs Peer
vs Settore
Rendimento basso
Прибутковість MLAB vs аналоги Life Sciences Tools & Services
ROE
-0,9%
▲
71%
sopra
peer
(-3,3%)
vs Peer
vs Settore
Sotto media
Net margin
-0,6%
▲
93%
sopra
peer
(-9,4%)
vs Peer
vs Settore
Sotto media
Валова маржа
62,2%
▲
29%
sopra
peer
(48,0%)
vs Peer
vs Settore
Top livello
ROA
-0,4%
▲
86%
sopra
peer
(-2,6%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя MLAB vs аналоги Life Sciences Tools & Services
D/E ratio
98,0
▲
168%
sopra
peer
(36,5)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
2,0
▼
40%
sotto
peer
(3,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,9
▼
38%
sotto
peer
(1,4)
vs Peer
vs Settore
Più volatile
Радар фундаменталів MLAB
MLAB
Mediana peer
Industria
MLAB прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
MLAB vs аналоги: ключові метрики
Ultime notizie
Nessuna notizia correlata ancora